Initial conservative management strategy of HeartWare left ventricular assist device thrombosis with intravenous heparin or bivalirudin.

Noelia Bouzas-CruzOscar Gonzalez-FernandezCarlos Ferrera-DuránAndrew WoodsNicola Robinson-SmithSian ToveyJérôme JungschlegerKaren BoothAsif ShahGareth ParryGuy A MacGowanStephan Schueler

Published in: The International journal of artificial organs (2019)

Left ventricular assist device thrombosis is a serious life-threatening complication; hence, we propose an initial conservative management of pump thrombosis with enhanced intravenous anticoagulation with either intravenous heparin or bivalirudin, with surgery reserved for refractory cases.

Keyphrases

left ventricular assist device
pulmonary embolism
venous thromboembolism
high dose
percutaneous coronary intervention
minimally invasive
growth factor
coronary artery bypass
atrial fibrillation
low dose
acute coronary syndrome
coronary artery disease